[1]
Miguel Reyes, J.L. et al. 2023. Benralizumab in severe eosinophilic asthma: A real-world, single-center, observational study from Mexico. Allergologia et Immunopathologia. 51, 6 (Nov. 2023), 8–15. DOI:https://doi.org/10.15586/aei.v51i6.852.